ETA2023 45th Annual Meeting of the European Thyroid Association ETA 2023 Oral Session 1: Highlights in Thyroidology: in Memory of Jacques Dumont (6 abstracts)
1Tilburg University, Clinical & Medical Health Psychology, Tilburg, Netherlands; 2Medical Centrum Twente; 3Máxima Medisch Centrum, Veldhoven, Netherlands; 4Academic Medical Centre, Endocrinology & Metabolism, Home, Amsterdam, Netherlands; 5Universary of Surrey, Faculty of Health & Medical Sciences, Guildford, United Kingdom
Background: Normal pregnancy is a state of physiological oxidative stress (OS) with oxidants facilitating the implantation of the embryo and optimal decidualisation but counterbalanced by antioxidants. Pro-oxidant processes exceeding the anti-oxidants capacity result in imbalanced OS, which has been associated with the big four obstetric complications: pre-term birth, intra-uterine growth retardation, pre-eclampsia and diabetes gravidarum. Important OS balance modulators are TH, hCG, CRP, the cytokine IL-6 and the iron status, often reflected by the serum ferritin level.
Rationale of the study: Early gestational hypothyroxinaemia has also repeatedly been associated with poor obstetric outcome and with impaired offspring neurodevelopment. Non-thyroidal illness has been conceptualized as a model of impaired balance of OS due to inflammation.
Aim of the study: In an area with sufficient iodine intake, to evaluate the possible association between 1st trimester hypothyroxinemia and the different parameters involved in OS including ferritin, IL-6, CRP, and hCG, adjusting for age and parity.
Methods: Between June 2018 and December 2022, the Brabant Study (BrSt) recruited 2835 pregnant women. We defined hypothyroxinaemia as FT4 < 5th percentile with TSH between 2.5-97.5th percentiles and a reference group with adequate FT4 levels, i.e., between 10 - 90th percentiles and normal TSH levels.
Results: 68 women on T4 replacement therapy were excluded and 12 women had incomplete data. Data-analysis refers to 2762 women. Of these, 122 had hypothyroxinaemia and 2114 belonged to the reference group. There were 147 women with low ferritin (< 5th percentile: < 17 µg/l), 129 women with high CRP (> 95th percentile: > 14.58 mg/l) and 136 women with a high Il-6 level (> 95th percentile: > 3.71 µg/l). Significantly more women with low ferritin, high CRP and high IL-6 status belonged to the hypothyroxinemic group compared to the control group (χ2 (1): 12.9, 11.1 and 10.9, all P < 0.001). Moreover, hypothyroxinemic women had significantly lower hCG levels (MW-U: Z = 4.6, P < 0.001) than the control group. Multiple logistic regression showed that hypothyroxinemia was independently associated with low iron status (OR: 3.6, 95%CI: 2.1-6.4), high CRP (OR: 2.1, 95%CI: 1.1-4.2), high IL-6 (OR: 2.3, 95%CI: 1.2-4.5), lower log hCG levels (OR: 6.6, 95%CI: 2.6-16.6), and higher age (OR: 1.08, 095%CI: 1.03-1.14).
Conclusion: Different modulators of OS which are all separately associated with poor obstetric outcome seem to be associated with hypothyroxinaemia during early gestation calling into question whether hypothyroxinaemia should be thought of as an example of OS, as reported in non-thyroidal illness.